
Lenalidomide Capsules
Multiple Myeloma, Myelodysplastic Syndromes
10mg
Lenalidomide 10mg hard capsules, used in the management of multiple myeloma and myelodysplastic syndromes. A thalidomide analogue and immunomodulator.
Lenalidomide is an immunomodulatory medicine used in specialist regimens for selected blood and bone-marrow disorders. It can cause severe birth defects and requires controlled prescribing and regular monitoring.

Multiple Myeloma, Myelodysplastic Syndromes
10mg
Lenalidomide 10mg hard capsules, used in the management of multiple myeloma and myelodysplastic syndromes. A thalidomide analogue and immunomodulator.
Listings are for comparison only. Suitability and supply depend on clinician and pharmacy checks, stock, destination rules and prescription requirements.
Lenalidomide may form part of treatment for multiple myeloma and selected myelodysplastic syndromes. The regimen depends on disease features, prior treatment and blood counts.
Lenalidomide changes immune signalling and the environment that supports abnormal blood cells. It also has direct effects on some malignant cells.
Pregnancy must be prevented according to the required programme, including precautions that may apply to partners. Blood counts, kidney function, clot risk and infection risk need review. Do not donate blood or share capsules. Other medicines in the cancer regimen can change both benefits and risks.
Seek urgent help for fever or signs of infection, unusual bleeding, chest pain, sudden breathlessness, coughing blood, one-sided leg pain or swelling, severe rash or facial swelling.